TrendsWide
Contact US
  • Home
  • Trending
  • Health
  • Life Style
  • NBA
  • Reviews
No Result
View All Result
TrendsWide
  • Home
  • Trending
  • Health
  • Life Style
  • NBA
  • Reviews
No Result
View All Result
TrendsWide
No Result
View All Result
Home Uncategorized

Scientists to develop live coronavirus vaccine in UK trial

by souhaib
September 29, 2020
in Uncategorized
0
74
SHARES
1.2k
VIEWS
Share on FacebookShare on Twitter
ADVERTISEMENT


You might also like

Agile Time Management Project Management

Pfizer says it expects data on COVID-19 vaccines for children in ‘early part of 2021’

John Oliver on the new 'Last Week Tonight' season and if Trump was good for comedy

Scientists ‘to infect 24 people in the UK’ with sluggish genetically-modified coronavirus to develop a ‘live’ vaccine that could produce Covid-19 immunity

  • Codagenix says its computer-edited virus is 1,000 times slower than real thing
  • Firm is said to be planning a ‘challenge trial’ to infect people after the jab
  • Live vaccine will provoke a more complete immune response, scientists say

By Sam Blanchard Senior Health Reporter For Mailonline

Published: 18:50 BST, 28 September 2020 | Updated: 08:30 BST, 29 September 2020

Up to two dozen people in Britain could be deliberately infected with a weakened form of coronavirus as part of a trial to develop a vaccine against Covid-19.

New York-based company Codagenix plans to begin experiments of its vaccine in London by the end of the year.

The jab will be of a type called a live attenuated vaccine, meaning people will be given a genetically-modified version of the coronavirus that is weaker than the real thing but still infectious.

Live attenuated vaccines — such as the MMR jab — work by stimulating the immune system in the same way that real Covid-19 would, but by relying on viruses unable to cause severe illness.

Codagenix says its vaccine was successful after a single dose in animal trials and is designed to produce immunity against various parts of the coronavirus, rather than just the ‘spike protein’ on the outside that many others have focused on.

This could mean it would still work even if the virus mutated. Using a live virus may enable medics to create a type of immunity that is similar to what the body would make naturally.

The trials will be held in the same facility as ‘challenge trials’ – in which people who have been vaccinated are deliberately exposed to the virus to test the jabs.

Codagenix has previously been reported to be joining the experiment. Details of exactly how the trial of the live attenuated vaccines will be structured have not yet been announced. 

Live attenuated vaccines work by stimulating the immune system in the same way that real Covid-19 would, but by relying on viruses unable to cause severe illness (stock image)

The version of the coronavirus used in Codagenix's vaccine is thought to multiply at around a thousandth of the rate of the wild virus (Pictured: The viruses in petri dishes, with the wild one on the left seen to be multiplying faster)

The version of the coronavirus used in Codagenix’s vaccine is thought to multiply at around a thousandth of the rate of the wild virus (Pictured: The viruses in petri dishes, with the wild one on the left seen to be multiplying faster)

The vaccine is likely to be trialled at a 24-bed clinic in Whitechapel, East London, where participants will be quarantined, The Times reports.  

The hVIVO clinic will also host ‘challenge trials’ of coronavirus vaccines, in which people who have had the jabs will be deliberately infected.

Although it is unclear whether Codagenix will take part in this, medical news website BioWorld reported in July that the company was planning to do so.

The company is understood to still be seeking approval from the UK’s drugs regulator to go ahead with its tests.

Codagenix’s vaccine will work by using a slowed-down version of the coronavirus and injecting it into participants. 

Covid-19’s ability to cause infection and serious disease relies on the virus multiplying rapidly inside the body before the immune system can stop it.

As it does this it can take over the lungs and blood vessels and cause the body to scramble to get rid of it, causing the tell-tale symptoms of fever and coughing, which are the immune system’s attempts to cook or expel the viruses. 

Codagenix’s weakened form of the virus, however, can only multiply about one thousandth as fast as the wild strain (0.1 per cent of the speed).

The company developed the weaker virus by changing its genetic code using a computer programme so that it looks exactly like the wild virus. 

Normally the coronavirus uses easy-to-decode sections of genes which allow it to hijack living cells and use them to multiply itself. The modified virus, however, takes significantly longer to achieve the same result.    

This means it cannot get a head-start on the immune system and the body should be able to destroy it – and form a memory of how to destroy it – before it can cause illness. 

Robert Coleman, the company’s CEO, told The Times: ‘We recode a portion of the virus’s genome so that it’s slowly translated by the human host. 

‘It’s like giving American high-school students Shakespearean English – they’ll read it, but they’ll have a hard time.’ 

Codagenix intends to make its vaccine one that will be administered by a nasal spray, as the flu jab is given to children.

UK TO HOST WORLD-FIRST ‘CHALLENGE TRIALS’ TO SPEED UP COVID-19 VACCINE DEVELOPMENT

British scientists will be the first in the world to carry out a controversial study where volunteers are deliberately infected with coronavirus in the race against time to find a vaccine, it was revealed today. 

The ‘challenge trial’ — which could rapidly accelerate the approval of experimental jabs — is said to be set to begin in January at a clinic in east London.

Participants will be infected with a dose of SARS-CoV-2, the virus that causes Covid-19, a month after being jabbed with a vaccine, according to the Financial Times.  

The study, reportedly funded by the government, could help drug-makers test their Covid-19 vaccines without having to wait for volunteers to naturally catch the virus in the community.   

Between 100 and 200 participants are expected to be recruited for the trial, which is being run by a US advocacy group that has campaigned for human challenge trials throughout the pandemic.

It’s unclear which vaccine candidate will be tested, but drug giants AstraZeneca and Sanofi have both insisted they aren’t taking part. MailOnline has approached Imperial College London — Britain’s other jab front-runner — for comment about its involvement.

Challenge trials are commonly deployed by scientists trying to develop a vaccine and have been used in malaria, typhoid and flu. But, unlike those illnesses, there is no proven treatment for people with mild coronavirus, so there is nothing to stop the participants falling seriously ill. 

The vaccine to be tested in the project has not been named, and organisers are said to have earmarked a quarantine clinic run by hVivo in Whitechapel, London, to carry out the trials. 

Drug researcher hVivo is linked to Queen Mary University of London, while Imperial College London is understood to be the project’s academic leader.

Around 2,000 potential volunteers have signed up to take part in challenge studies in the UK. 

They have done so through 1Day Sooner, a US-based advocacy group which is made up of 100 leading experts including Nobel Prize-winning scientists.

Share or comment on this article:





Source link

Share this:

  • Twitter
  • Facebook
  • More
  • Pinterest
  • Telegram
  • Email
Tags: bbc healthdailymail heath
Share30Tweet19
Previous Post

Term life insurance: How to get the cheapest quote

Next Post

Heather Watson crashes out of French Open after losing in straight sets to Fiona Ferro

souhaib

Recommended For You

Agile Time Management Project Management

by souhaib
March 19, 2021
0

Time management Project management is very important.  If you are an owner of the company often the CEO without being the managing director, the one who must be...

Read more

Pfizer says it expects data on COVID-19 vaccines for children in ‘early part of 2021’

by souhaib
February 11, 2021
0

Both Pfizer Inc and Moderna Inc say they expect to have data on how well their coronavirus vaccines work in teenagers later this year.Currently, immunizations against COVID-19 are...

Read more

John Oliver on the new 'Last Week Tonight' season and if Trump was good for comedy

by souhaib
February 11, 2021
0

John Oliver talked with USA TODAY TV Editor Gary Levin about the new season of "Last Week Tonight" and why he won't miss President Trump.        Source link

Read more

Dr Fauci declares April ‘open season’ for COVID-19 vaccinatoins

by souhaib
February 11, 2021
0

Dr Fauci declares April 'open season' for any American adult to get a COVID-19 vaccine and predicts the 'majority' of Americans will have two doses by fallDr Anthony...

Read more

Biden administration fears it could take nine months to reach herd immunity

by souhaib
February 11, 2021
0

The US may not reach herd immunity and return to some semblance of normalcy until Thanksgiving at the current pace of COVID-19 vaccinations and speed of variant spread,...

Read more
Next Post

Heather Watson crashes out of French Open after losing in straight sets to Fiona Ferro

No Result
View All Result

Recent Posts

  • How To Quickly Reach Quality Hires For Your SMB
  • The euro stabilizes around 1.02 dollars By EFE
  • World Bank announces new $4.5 billion aid for Ukraine
  • Model correct with these wavy hair wigs and glance lovely
  • Norway threatens to ration electricity in fresh blow for UK energy supplies

Browse by Category

  • Australia
  • Automotive
  • Business
  • Celebrity
  • Cryptocurrency
  • Deals
  • Economie
  • Education
  • Euro
  • Forex
  • Gaming
  • Health
  • Life Style
  • NBA
  • News
  • Reviews
  • Sports
  • Switzerland
  • Trending
  • U.S.
  • Uncategorized

Categories

  • Australia
  • Automotive
  • Business
  • Celebrity
  • Cryptocurrency
  • Deals
  • Economie
  • Education
  • Euro
  • Forex
  • Gaming
  • Health
  • Life Style
  • NBA
  • News
  • Reviews
  • Sports
  • Switzerland
  • Trending
  • U.S.
  • Uncategorized

Pages

  • Contact US
  • Newsletter
  • Privacy Policy
  • Terms & Conditions

© 2021 - TrendsWide

No Result
View All Result
  • Home
  • Contact US
  • Privacy Policy
  • Trending
  • U.S.
  • Economie
  • Deals
  • Reviews
  • Cryptocurrency
  • Health
  • Life Style
  • NBA

© 2021 - TrendsWide